Citation: C. Pitts et al., Interaction energy analysis of nonclassical antifolates with human dihydrofolate reductase, J MOL MODEL, 6(6), 2000, pp. 467-476
Authors:
Bowen, D
Southerland, WM
Johnson, DH
Hawkins, M
Hughes, DE
Citation: D. Bowen et al., Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells, CANCER DET, 24(5), 2000, pp. 452-458
Authors:
Bowen, D
Southerland, WM
Hawkins, M
Johnson, DH
Citation: D. Bowen et al., Sequence-dependent antagonism between tamoxifen and methotrexate in human breast cancer cells, ANTICANC R, 20(3A), 2000, pp. 1415-1417
Authors:
Bowen, D
Johnson, DH
Southerland, WM
Hughes, DE
Hawkins, M
Citation: D. Bowen et al., Selectivity in human breast cancer and human bone marrow using trimetrexate in combination with 5-fluorouracil, ANTICANC R, 19(5B), 1999, pp. 3837-3840
Authors:
Bowen, D
Johnson, DH
Southerland, WM
Hughes, DE
Hawkins, M
Citation: D. Bowen et al., 5-fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity inhuman bone marrow, ANTICANC R, 19(2A), 1999, pp. 985-988
Citation: R. Pan et al., Molecular modelling of trimethoprim complexes of human wild-type and mutant dihydrofolate reductases: Identification of two subsets of binding residues in the antifolate binding site, BIOPHARM DR, 20(7), 1999, pp. 335-340